Pfizer
NEWS
During its financial report this morning, Pfizer released an update of its pipeline which includes the discontinued projects.
This is a market like the world has never seen.
We are still only in January and Celgene and Sanofi have already made a combined $20B in M&A deals.
The companies will collaborate on research to study a previously unrecognized role for peripheral immune cells in the pathology of central nervous system disorders.
The year is already off to a good start with mergers and acquisitions in the biopharma industry.
Life sciences professionals don’t have to look far for opportunity in Genetown.
The company, which now has 11 personnel, is a CRO focused on infectious disease research.
GlaxoSmithKline CEO Emma Walmsley is eying a big acquisition to spur revenue growth but is making sure that her company will not overpay.
Since the acquisition fell apart, Allergan has fallen on some hard times.
JOBS
IN THE PRESS